SUMMARY Seventy seven sera with antimitochondrial antibody exhibiting the M2-M4 pattern in immunofluorescence (56 from primary biliary cirrhosis (PBC), 21 from non-primary biliary cirrhosis patients) were studied by the combined use of Western immunoblotting with beef heart mitochondria and an enzyme linked immunosorbent assay (ELISA) with beef heart submitochondrial particles. Forty seven sera (10 without autoantibodies and 37 with different autoantibodies) were included as controls. By immunoblotting, seven mitochondrial peptides reacting with antimitochondrial antibody positive sera were detected. These were of molecular weight 74 kD, 58 kD, 55 kD, 52 kD, 51 kD, 46 kD, and 43 kD. All primary biliary cirrhosis sera and 71% of antimitochondrial antibody-positive non-primary biliary cirrhosis sera reacted with one or more of these peptides, while none of the 47 antimitochondrial antibody negative sera reacted in immunoblotting. The 74 kD band was the most frequently detected (84% of primary biliary cirrhosis and 57% of non-primary biliary cirrhosis cases). All the primary biliary cirrhosis sera which failed to react with this peptide, showed a positive reaction with that of molecular weight 52 kD. 67/77 (87%) immunofluorescence antimitochondrial antibody positive sera reacted in the ELISA test (93% of primary biliary cirrhosis and 71% of non-primary biliary cirrhosis cases). All the 47 immunofluorescence antimitochondrial antibody negative sera were confirmed negative by ELISA. The ELISA values correlated with the immunofluorescence titres (p<005). By comparison of the results obtained by these two techniques, it emerged that the ELISA test (using our preparation of submitochondrial particles) was not able to detect the antibody directed against the mitochondrial peptide of 52 kD, which thus seems to be different from the other specificities.
The aim of the present study is to compare the reactivities of the antimitochondrial antibody (with the M2-M4 immunofluorescence pattern) present in primary biliary cirrhosis and non-primary biliary cirrhosis sera, using immunoblotting and ELISA, in order to define if there are any differences in the antigen specificities of the antibodies detected by these methods in these two distinct groups of patients.
Methods

PATIENTS
SERA
Fifty six primary biliary cirrhosis sera with M2-M4 immunofluorescence antimitochondrial antibody reactivity were studied. The diagnosis of primary biliary cirrhosis was based on clinical, biochemical and histological data.'9 Twenty seven patients were histologically classified in Stage I-1I and 29 in Stage III-IV. Twenty one M2-M4 immunofluorescence antimitochondrial antibody positive sera from nonprimary biliary cirrhosis patients were also studied. These were from patients with cryptogenic chronic active hepatitis (three), connective tissue disorders (four), vitiligo (two), alopecia (one), Type I diabetes (one), hypothyroidism (one), Type II diabetes (two), Cushing syndrome (one), lung neoplasm (one), bronchial pneumonia (one), atherosclerosis (one), food allergy (one), hiatal hernia (one), and one healthy subject. None of the non-primary biliary cirrhosis patients, except the three chronic active hepatitis cases, showed any clinical or biochemical feature of liver damage. Three percutaneous liver biopsies from patients without evidence of liver disease (one vitiligo and two Type II diabetes) were carried out and histologically they were normal. As controls, we also studied 10 sera from healthy subjects without autoantibodies and 37 sera with a variety of non-organ and organ-specific autoantibodies: anti-nuclear antibody (five), liver kidney microsomal antibody (three), rheumatoid factor (10), human parietal cell antibody (four), islet cell antibody (five), thyroid microsomal (five), and thyroglobulin (five) antibodies.
IMMUNOFLUORESCENCE STUDIES
Antimitochondrial antibody as well as anti-nuclear antibody, liver kidney microsomal antibody, parietal cell antibody, and islet cell antibody were initially detected by the standard indirect immunofluorescence technique using cryostat sections from composite blocks of rat liver and kidney, human stomach and pancreas. For non-organ specific autoantibodies (antimitochondrial antibody, anti-nuclear antibody, liver kidney microsomal antibody), the screening dilution of the sera was 1:10, while for the organ specific ones (parietal cell antibody, islet cell antibody) the sera were tested undiluted. Antimitochondrial antibody were titrated by serial dilution to end point. Thyroglobulin, thyroid microsomal and rheumatoid factor were detected by commercial haemoagglutination kits.
MITOCHONDRIAL ANTIGEN PREPARATION
Mitochondria were first isolated from beef heart according to Beinert20 and submitochondrial particles were then prepared according to Hanson 
with beef heart submitbchondrial particles. Results are summarised in Figure 2 . The ELISA values of primary biliary cirrhosis positive antimitochondrial antibody sera (median 6.7, range 0-5-13.4) were significantly higher (p<0-01) than those of nonprimary biliary cirrhosis patients with the same immunofluorescence specificity (median 2.6, range 0-5-10.2). A positive correlation was found between the ELISA results and the immunofluorescence titres (p<005) (Fig. 3) .
The relationship between immunoblotting and ELISA results is shown in Table 3 . Grouping the sera on the basis of their ELISA values, 100% of ELISA strongly positive sera (+ +) reacted with the 74 kD, 92% with the 55 kD, 48% with the 51 kD, and 66% with the 43 kD peptide, while only 47%, 24%, 0%, and 17% of the ELISA weakly positive sera (+) reacted with the above four proteins, respectively. On the whole, ELISA and immunoblotting reactions, although carried out with different antigens (submitochondrial particles are known to contain mainly inner mitochondrial membranes), correlated for all the proteins detected by immunoblotting except for the 52 kD peptide, which was apparently detected regardless of the ELISA results (52%, 47%, and 60% of ELISA+ +, +, and negative sera, respectively). All the four ELISA negative primary biliary cirrhosis sera turned out to be positive for the 52 kD protein in immunoblotting. The statistical significance of the correlation between ELISA and immunofluorescence titres increased to p<0-001 when considering only the sera reacting in immunoblotting with the 74 kD protein (Fig. 3) .
Discussion
Using Western immunoblotting analysis with beef heart mitochondrial proteins as antigenic substrate, the heterogeneity of anti-mitochondrial antibodies with M2-M4 immunofluorescence pattern is largely confirmed. In fact, we were able to detect seven different peptides of molecular weight (MW) 74 Considering the anti-mitochondrial antibodies from primary biliary cirrhosis cases, 84% recognised the 74 kD protein (often in association with the 52 kD band), while the remaining 16% were negative for the 74 kD band but invariably reacted with the 52 kD one. In the ELISA test the intensity of the reactions correlated with all of the bands detected by immunoblotting except for that of 52 kD. Moreover, the correlation between the ELISA results and the immunofluorescence titres significantly increases (from p<O05 to p<O-OO1) when sera reacting with this latter protein only were excluded. Thus, it is tempting to conclude that the 52 kD peptide is the target of a mitochondrial specificity different from that at 74 kD MW.
No clearcut conclusion is at present available on the relationship between antimitochondrial antibody specificities detected by complement fixation test, ELISA, immunodiffusion and immunoblotting. The presence in a crude preparation of F1-ATPase (released from submitochondrial particles by chloroform treatment) has been taken as a characteristic of the M2 antigen.26 Because of its high prevalence of reactivity with immunofluorescence antimitochondrial antibody positive primary biliary cirrhosis sera and its presence in such a preparation of F1-ATPase (data not shown), it is suggested that the 74 kD peptide is the major antigenic component of M2. In the same time the hypothesis is advanced that the 52 kD reactivity may be associated with the M4 antimitochondrial antibody: in fact, the M4 antigen has been localised in the outer mitochondrial membrane,4 and it is well known that submitochondrial particles (used in our ELISA as source of antigen) are mainly composed of inner mitochondrial membranes and may, at least in our preparation, have had very little outer membranes contamination. Moreover, the three immunofluorescence antimitochondrial antibody positive sera from chronic active hepatitis patients were negative for the 74 kD band and two reacted with the 52 kD one. There are two further clear distinctions between the 52 kD peptide and the other reactivities. First, sera reacting only with the 52 kD peptide do not react against the chloroform released F1-ATPase preparation (data not shown), second, the molecular weight of the '74 kD family' may vary significantly depending upon the species from which mitochondria are prepared,25 whereas the molecular weight of the 52 kD band is species independent (data not shown).
These data suggest the existence of an immunological heterogeneity within primary biliary cirrhosis patients, which can be divided in three different subgroups: one with 74 kD (45%), one with 74 kD and 52 kD (39%), and one with 52 kD (16%) reactive antimitochondrial antibody. Several lines of evidence indicate that primary biliary cirrhosis is indeed an heterogeneous entity, including its clinical spectrum2' and natural history.' Grouping our cases on the basis of these different antimitochondrial antibody specificities, the association of the reactivities at 74 kD and 52 kD molecular weight seems to be more frequent in the advanced histological stages of the disease (Table 4) , but this was not statistically significant. No other clinical or biochemical differences were found among these three subgroups. It might by hypothesised that the group with the M2 reactivity -the 74 kD band by immunoblotting -will develop, in time, antibodies against the 52 kD one, while there is another group, which lacks the M2 reactivity and reacts only with the 52 kD band. No differences were found between this latter group and all of the other primary biliary cirrhosis patients, but it must be stressed that we do not have information about responses to treatment in these cases.
In the non-primary biliary cirrhosis group with M2-M4 immunofluorescence pattern the immunoblotting test, when positive, was similar to that given by primary biliary cirrhosis sera. It must be stressed 
